Sullivan Christopher Ryan - Insider Non-Derivative Transactions at Avalo Therapeutics, Inc. (AVTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 10, 2025, Sullivan Christopher Ryan's relationship to Avalo Therapeutics, Inc. (AVTX) is Officer (Chief Financial Officer), and currently has 17,338 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AVTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Sullivan Christopher Ryan - Insider Non-Derivative Transactions of AVTX Common Stock

Sullivan Christopher Ryan - Insider Non-Derivative Transactions at AVTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 11, 2025	F -- (Common Stock)	155	4.1	17338
Mar 29, 2025	F -- (Common Stock)	7285	8.46	16921
Mar 29, 2025	M -- (Common Stock)	24200	0	24206
Jun 10, 2023	P -- (Common Stock)	511	3.42	1262